Description

Evroxim Powder for Injections 750 mg. №10 Vial

Ingredients:

Each vial contains 750 mg of Evroxim powder for injections.

Mechanism of Action:

Evroxim acts by inhibiting bacterial cell wall synthesis, resulting in bacterial cell death. It binds to penicillin-binding proteins to exert its antimicrobial effects.

Pharmacological Properties:

Evroxim is a broad-spectrum antibiotic with potent activity against susceptible organisms, making it effective in treating various bacterial infections.

Indications for Use:

Evroxim is indicated for the treatment of bacterial infections caused by susceptible organisms. It is commonly employed in serious infections such as pneumonia, septicemia, and skin infections.

Contraindications:

Do not use Evroxim if you have a known allergy to any of its components or if you have a history of severe allergic reactions to antibiotics. Consult a healthcare provider before use.

Side Effects:

Common side effects of Evroxim may include gastrointestinal disturbances, allergic reactions, and skin rashes. Contact your healthcare provider if any adverse reactions occur.

Usage Instructions:

Administer Evroxim as prescribed by a healthcare professional. Follow the specific instructions provided for reconstitution and administration of the medication.

Benefits Compared to Analogues:

Evroxim has demonstrated superior efficacy in combating resistant bacterial strains compared to similar antibiotics, making it a valuable option in the management of challenging infections.

Suitable Patient Groups:

Evroxim can be used in various patient groups, including adults, children, and the elderly, under appropriate medical supervision.

Storage and Shelf Life:

Store Evroxim according to the instructions provided on the packaging. Check the expiration date and do not use expired medication.

Packaging Description:

Evroxim is available in 750 mg powder for injections in a package containing 10 vials. Each vial is designed for single-use only.

Clinical Evidence and Proven Effectiveness:

Evroxim has been extensively studied in clinical trials, demonstrating efficacy in treating multidrug-resistant bacterial infections. Research published in reputable journals has highlighted its success in resolving infections compared to other antibiotics in its class.